BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 23354167)

  • 21. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
    Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis.
    Zhang Y; Yang P; Sun T; Li D; Xu X; Rui Y; Li C; Chong M; Ibrahim T; Mercatali L; Amadori D; Lu X; Xie D; Li QJ; Wang XF
    Nat Cell Biol; 2013 Mar; 15(3):284-94. PubMed ID: 23396050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
    Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
    Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
    Kim KS; Kim J; Oh N; Kim MY; Park KS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):509-515. PubMed ID: 29510139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A.
    Kong Y; Zou S; Yang F; Xu X; Bu W; Jia J; Liu Z
    Cancer Lett; 2016 Oct; 381(1):138-48. PubMed ID: 27497248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer.
    Li Y; Zhang Z; Xiao Z; Lin Y; Luo T; Zhou Q; Zhang X
    Oncotarget; 2017 Feb; 8(9):14655-14665. PubMed ID: 28122338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer.
    Liu Y; Zhang J; Sun X; Su Q; You C
    Oncotarget; 2017 Jun; 8(24):39559-39570. PubMed ID: 28465475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision.
    Ma J; Liu C; Yang D; Song J; Zhang J; Wang T; Wang M; Xu W; Li X; Ding S; Zhan J; Zhang H
    Sci China Life Sci; 2019 Sep; 62(9):1229-1242. PubMed ID: 31376015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
    Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
    J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer.
    Bai F; Zhang LH; Liu X; Wang C; Zheng C; Sun J; Li M; Zhu WG; Pei XH
    Theranostics; 2021; 11(17):8218-8233. PubMed ID: 34373738
    [No Abstract]   [Full Text] [Related]  

  • 32. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
    Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
    Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunction of the Reciprocal Feedback Loop between GATA3- and ZEB2-Nucleated Repression Programs Contributes to Breast Cancer Metastasis.
    Si W; Huang W; Zheng Y; Yang Y; Liu X; Shan L; Zhou X; Wang Y; Su D; Gao J; Yan R; Han X; Li W; He L; Shi L; Xuan C; Liang J; Sun L; Wang Y; Shang Y
    Cancer Cell; 2015 Jun; 27(6):822-36. PubMed ID: 26028330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
    Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
    Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
    Ma L; Teruya-Feldstein J; Weinberg RA
    Nature; 2007 Oct; 449(7163):682-8. PubMed ID: 17898713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
    Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
    Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin.
    Zhang N; Wang X; Huo Q; Sun M; Cai C; Liu Z; Hu G; Yang Q
    Oncogene; 2014 Jun; 33(24):3119-28. PubMed ID: 23851509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
    Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
    Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
    Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
    Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.